|
US1005A
(en)
*
|
|
1838-11-12 |
|
Ing and heating booms and other apabtments beqtjibing abtrficial |
|
ZA716628B
(en)
|
1970-10-15 |
1972-06-28 |
Richardson Merrell Spa |
Composition and method for treatment of hepatic disease and mental fatigue
|
|
US4196265A
(en)
*
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4458066A
(en)
*
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
NL8102724A
(nl)
|
1980-07-11 |
1982-02-01 |
Stamicarbon |
Werkwijze voor de bereiding van copolymeren van etheen met tenminste een ander 1-alkeen.
|
|
US4554101A
(en)
*
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US4769331A
(en)
*
|
1981-09-16 |
1988-09-06 |
University Patents, Inc. |
Recombinant methods and materials
|
|
US4736866B1
(en)
*
|
1984-06-22 |
1988-04-12 |
|
Transgenic non-human mammals
|
|
US4965188A
(en)
*
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
*
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5573933A
(en)
*
|
1987-04-14 |
1996-11-12 |
Luminis Pty, Ltd. |
Transgenic pigs
|
|
US4996236A
(en)
*
|
1988-06-22 |
1991-02-26 |
Takeda Chemical Industries, Ltd. |
Therapeutic composition for hepatic encephalopathy
|
|
US5162215A
(en)
*
|
1988-09-22 |
1992-11-10 |
Amgen Inc. |
Method of gene transfer into chickens and other avian species
|
|
US5399346A
(en)
*
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5286634A
(en)
*
|
1989-09-28 |
1994-02-15 |
Stadler Joan K |
Synergistic method for host cell transformation
|
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
EP0441119A3
(en)
*
|
1990-01-09 |
1992-10-14 |
Richard D. Levere |
The use of l-arginine in the treatment of hypertension and other vascular disorders
|
|
US5279833A
(en)
*
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5614396A
(en)
*
|
1990-06-14 |
1997-03-25 |
Baylor College Of Medicine |
Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
|
|
US5489742A
(en)
*
|
1990-10-23 |
1996-02-06 |
Board Of Regents, The University Of Texas System |
Transgenic rats and animal models of inflammatory disease
|
|
US5641484A
(en)
*
|
1990-12-04 |
1997-06-24 |
Board Of Regents, The University Of Texas System |
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
|
|
WO1992010573A1
(en)
*
|
1990-12-04 |
1992-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the suppression of neu mediated transformation
|
|
US5643567A
(en)
*
|
1990-12-04 |
1997-07-01 |
Board Of Regents, The University Of Texas System |
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
|
|
DE69127756T2
(de)
*
|
1990-12-05 |
1998-02-05 |
The General Hospital Corp., Charlestown, Mass. |
Verwendung von no zur behandlung oder prävention der bronchokonstriktion
|
|
US5550316A
(en)
*
|
1991-01-02 |
1996-08-27 |
Fox Chase Cancer Center |
Transgenic animal model system for human cutaneous melanoma
|
|
US5550024A
(en)
*
|
1991-04-19 |
1996-08-27 |
Biotechnology Research & Development Corporation |
Genetic markers for pig litter size
|
|
US5334380A
(en)
*
|
1991-09-27 |
1994-08-02 |
Board Of Regents, The University Of Texas System |
Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
|
|
US5286739A
(en)
*
|
1991-09-27 |
1994-02-15 |
Board Of Regents, University Of Texas System |
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
|
|
US5374651A
(en)
*
|
1991-09-27 |
1994-12-20 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
|
|
US5385940A
(en)
*
|
1992-11-05 |
1995-01-31 |
The General Hospital Corporation |
Treatment of stroke with nitric-oxide releasing compounds
|
|
WO1994016740A1
(en)
|
1993-01-29 |
1994-08-04 |
Brigham And Women's Hospital |
The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
|
|
US5891459A
(en)
*
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
|
US5646008A
(en)
*
|
1993-06-22 |
1997-07-08 |
The Regent Of The University Of Michigan |
Vertebrate apoptosis gene: compositions and methods
|
|
US5625125A
(en)
*
|
1994-08-09 |
1997-04-29 |
Dnx Biotherapeutics |
Phospholipase A2 expressing transgenic animals
|
|
US5543430A
(en)
*
|
1994-10-05 |
1996-08-06 |
Kaesemeyer; W. H. |
Method and formulation of stimulating nitric oxide synthesis
|
|
US5648061A
(en)
*
|
1995-05-24 |
1997-07-15 |
Thomas Jefferson University |
In vivo and in vitro model of cutaneous photoaging
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
US5874471A
(en)
*
|
1997-02-27 |
1999-02-23 |
Waugh; William Howard |
Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
|
|
US6028107A
(en)
*
|
1997-02-27 |
2000-02-22 |
Waugh; William Howard |
Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
|
|
AU9596698A
(en)
|
1997-10-15 |
1999-05-03 |
Thomas Jefferson University |
Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
|
|
US6796966B2
(en)
*
|
1997-10-15 |
2004-09-28 |
Jeffrey E. Thomas |
Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
|
|
US20010056068A1
(en)
*
|
1998-03-04 |
2001-12-27 |
Kristof Chwalisz |
Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives
|
|
US20020068365A1
(en)
|
1998-07-28 |
2002-06-06 |
Eric H. Kuhrts |
Controlled release nitric oxide producing agents
|
|
US6346382B1
(en)
*
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
|
US9486429B2
(en)
|
1999-06-01 |
2016-11-08 |
Vanderbilt University |
Therapeutic methods employing nitric oxide precursors
|
|
US6182295B1
(en)
*
|
1999-06-14 |
2001-02-06 |
Kevin Sciglia |
Hat
|
|
CN1166339C
(zh)
*
|
1999-11-15 |
2004-09-15 |
Lg电子株式会社 |
旋风真空吸尘器中的用于集尘箱的联结装置
|
|
JP3506114B2
(ja)
|
2000-01-25 |
2004-03-15 |
株式会社ニコン |
モニタ装置及びこのモニタ装置を具えた研磨装置及び研磨方法
|
|
US6689810B2
(en)
*
|
2001-08-21 |
2004-02-10 |
Cellular Sciences, Inc. |
Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
|
|
EP1448600A4
(en)
*
|
2001-09-07 |
2004-12-22 |
Bristol Myers Squibb Co |
POLYNUCLEOTIDE ENCODING A NOVEL HUMAN G PROTEIN-RELATED RECEPTOR, HGPRMBY39
|
|
US20030134332A1
(en)
*
|
2001-11-28 |
2003-07-17 |
Boykin Joseph V. |
Diagnosis of endothelial dysfunction by nitric oxide bioactivity index
|
|
JP2008526868A
(ja)
*
|
2005-01-06 |
2008-07-24 |
ディスカバリー ラボラトリーズ，インコーポレイテッド |
表面活性剤処置療法
|
|
CA2632238A1
(en)
*
|
2005-12-01 |
2007-06-07 |
Nps Pharmaceuticals, Inc. |
A biomarker of improved intestinal function
|
|
KR20170005155A
(ko)
*
|
2008-01-31 |
2017-01-11 |
반더빌트유니버시티 |
폐의 용태에 따른 치료 방법
|
|
PL2240170T3
(pl)
*
|
2008-01-31 |
2019-11-29 |
Univ Vanderbilt |
Sposoby i kompozycje do leczenia wieńcowego i tętniczego tętniakowego krwotoku podpajęczynówkowego
|